Noriyuki Ozaki Selected Research

Noriyuki Ozaki Research Topics

Disease

14	Hyperalgesia 01/2022 - 09/2005
7	Pain (Aches) 11/2019 - 09/2005
3	Neuralgia (Stump Neuralgia) 01/2022 - 07/2007
3	Hypersensitivity (Allergy) 01/2022 - 11/2019
3	Myalgia 11/2013 - 11/2008
3	Neoplasms (Cancer) 10/2012 - 09/2005
2	Inflammation (Inflammations) 01/2022 - 09/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2014 - 05/2010
2	Body Weight (Weight, Body) 01/2010 - 10/2007
2	Obesity 01/2010 - 10/2007
2	Polyuria 05/2009 - 11/2008
1	Botulism 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Rupture 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Chronic Pain 01/2021
1	Glioma (Gliomas) 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Diabetes Mellitus 01/2018
1	Arthritis (Polyarthritis) 09/2017
1	Atrophy 01/2016
1	Cold Hypersensitivity 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Musculoskeletal Pain 11/2013
1	Diabetes Insipidus 05/2009
1	Polydipsia 11/2008
1	Nephrogenic Diabetes Insipidus 11/2008
1	Visceral Pain 04/2008
1	Insulin Resistance 03/2007
1	Fibrosis (Cirrhosis) 11/2006

Drug/Important Bio-Agent (IBA)

3	Nerve Growth Factor (NGF)IBA 09/2018 - 10/2011
3	Morphine (MS Contin)FDA LinkGeneric 09/2017 - 08/2008
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2008
2	Acid Sensing Ion ChannelsIBA 11/2019 - 11/2008
2	Analgesics (Analgesic Drugs)IBA 09/2018 - 09/2017
2	Ion Channels (Ion Channel)IBA 05/2010 - 11/2008
2	Vasopressins (Vasopressin)IBA 05/2009 - 11/2008
2	capsazepineIBA 08/2008 - 09/2005
2	TRPV Cation ChannelsIBA 09/2006 - 09/2005
1	Amino Acids FDA Link 01/2022
1	CathepsinsIBA 01/2022
1	Choline (Choline Chloride)IBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2022
1	Clodronic Acid (Clodronate)IBA 01/2022
1	HhAntag691IBA 01/2022
1	betaninIBA 01/2021
1	Neutralizing AntibodiesIBA 11/2019
1	Corticotropin-Releasing HormoneIBA 11/2019
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 11/2019
1	CytokinesIBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	CuprizoneIBA 01/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	INCB3344IBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2016
1	sperm releasing substanceIBA 01/2016
1	NC-4016IBA 01/2014
1	1,2-cyclohexanediamine (dach)IBA 01/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014
1	MicellesIBA 01/2014
1	OxalatesIBA 01/2014
1	PlatinumIBA 01/2014
1	Platinum Compounds (Compounds, Platinum)IBA 01/2014
1	NitrogenIBA 10/2012
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 10/2011
1	staurosporine aglycone (K252a)IBA 10/2011
1	Cisplatin (Platino)FDA LinkGeneric 05/2010
1	GhrelinIBA 01/2010
1	Messenger RNA (mRNA)IBA 05/2009
1	Neurophysins (Neurophysin I)IBA 05/2009
1	Arginine Vasopressin (Argipressin)IBA 05/2009
1	Carrier Proteins (Binding Protein)IBA 05/2009
1	CarrageenanIBA 11/2008
1	LithiumIBA 11/2008
1	Aquaporin 2IBA 11/2008
1	Ruthenium RedIBA 08/2008
1	Mitogen-Activated Protein KinasesIBA 04/2008
1	Protein Kinases (Protein Kinase)IBA 04/2008
1	Mitogen-Activated Protein Kinase 3IBA 04/2008
1	GABA-B Receptor AgonistsIBA 10/2007
1	Neuropeptide YIBA 10/2007
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2007
1	Indicators and Reagents (Reagents)IBA 10/2007
1	Baclofen FDA LinkGeneric 10/2007
1	Purinergic P2X3 ReceptorsIBA 07/2007
1	Insulin (Novolin)FDA Link 03/2007
1	melanotan-IIIBA 03/2007
1	MelanocortinsIBA 03/2007
1	Purinergic P2 Receptors (ADP Receptor)IBA 09/2006
1	Calcitonin Gene-Related PeptideIBA 09/2006

Therapy/Procedure

3	Therapeutics 09/2018 - 07/2007
2	Ligation 01/2016 - 07/2007
2	Intramuscular Injections 11/2013 - 11/2008
1	Craniotomy 01/2020
1	Drug Therapy (Chemotherapy) 01/2014
1	Injections 11/2013
1	Denervation 11/2006